CompletedPHASE1, PHASE2NCT00412243

Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
M.D. Anderson Cancer Center
Principal Investigator
Stefan Faderl, MD
M.D. Anderson Cancer Center
Intervention
Clofarabine(drug)
Enrollment
51 enrolled
Eligibility
21 years · All sexes
Timeline
20062012

Study locations (1)

Collaborators

Genzyme, a Sanofi Company

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00412243 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials